Document is current

Any future updates will be listed below

Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients: a Meta-analysis

Crossref DOI link: https://doi.org/10.1007/s11596-018-1844-y

Published Online: 2018-03-15

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark